Effect of radiotherapy on cardiac-specific death in patients with non-malignant tumors of central nervous system and related clinical features

Ruxin Wang, Haowen Ye, Yongting Zhao, Li Ma, Jinjing Wei, Ying Wang, Xiaofang Zhang, Lihong WangFrontiers in Cardiovascular Medicine 2022 · DOI

TL;DR

While radiotherapy (RT) is notorious for its cardiotoxic side effects in cancer treatment, a new study reveals a surprising trend: for patients with non-malignant central nervous system (CNS) tumors, RT is actually associated with a lower risk of cardiac-specific death. This suggests that for benign or borderline brain and spinal tumors, the cardiovascular benefits of controlling tumor growth may outweigh the potential risks of radiation exposure.

What Problem Does This Paper Address?

In the world of oncology, radiotherapy is a double-edged sword. While it kills tumor cells, it can also damage healthy tissue—most notably the heart. Extensive research has documented radiation-induced heart disease in patients with malignant cancers (like breast cancer or Hodgkin’s lymphoma). However, we know very little about how RT affects the hearts of patients with non-malignant (benign or borderline) tumors of the brain and spinal cord.

These patients often have high survival rates, making long-term side effects like heart disease a primary concern. Furthermore, the "neuro-cardiological axis" suggests that CNS tumors can indirectly impair heart function by compressing brain regions that regulate the autonomic nervous system. The researchers sought to determine if RT in this specific population increases or decreases the risk of dying from heart disease.

Methods

The researchers conducted a large-scale retrospective cohort study using data from the SEER database (2000–2019). To ensure a fair comparison between patients who received RT and those who didn't, they employed Propensity Score Matching (PSM).

PSM is a statistical technique that mimics a randomized controlled trial by matching patients from both groups based on shared characteristics (like age, sex, and race), effectively reducing "apples-to-oranges" bias. They then used multivariate logistic regression to identify independent risk factors for cardiac-specific death.

Datasets

The study utilized the Surveillance, Epidemiology, and End Results (SEER) database, which:

  • Covers approximately 30% of the U.S. population across 18 registries.
  • Included a massive cohort of 233,306 patients with non-malignant CNS tumors.
  • Categorized tumors into "Benign" and "Borderline malignancy" based on ICD-O-3 codes.

Key Insights and Ideas

  • The Protective Effect of RT: The most striking finding was that RT was associated with a significantly lower risk of cardiac-specific death. This is counter-intuitive compared to thoracic (chest) radiation. The authors hypothesize that by shrinking benign tumors, RT relieves pressure on the CNS, thereby stabilizing the "neuro-cardiological axis" and preventing brain-heart syndrome.
  • Demographic Disparities: The study highlighted significant social determinants of health. Black patients and those with lower income levels faced a higher risk of cardiac death, while married status and female sex were protective factors.
  • Tumor Characteristics Matter: Larger tumors and bilateral tumors (occurring on both sides) were significant risk factors. Interestingly, the specific site of the tumor played a role; tumors in the nervous system (excluding nerve and endocrine sites) generally showed lower risks of cardiac death when treated.
  • Temporal Trends: Patients diagnosed in earlier years (e.g., 2004–2007) had a much higher risk of cardiac death compared to those diagnosed more recently (2016–2019), likely reflecting improvements in both radiation precision and cardiovascular care.

Key Results

  • Reduced Risk: For patients with non-malignant CNS tumors, receiving RT was associated with a lower risk of cardiac-specific death (Odds Ratio [OR] 0.792 after PSM, p < 0.001).
  • Incidence: The incidence of cardiac death was 15.2% in the RT group compared to 17.5% in the non-RT group.
  • Risk Factors:
    • Age: Older age at diagnosis was a major risk factor (OR 1.080).
  • Race: Black patients had higher risks compared to White, Asian, or American Indian populations.
  • Tumor Size: Larger tumors were consistently linked to higher mortality.
  • Protective Factors: Female sex (OR 0.677), being married (OR 0.733), and undergoing surgery (OR 0.870) were all associated with lower risks of cardiac death.

Limitations and Future Work

The authors acknowledge several limitations inherent in using the SEER database:

  1. Lack of Granularity: The database does not include specific radiation doses, volumes, or the exact technologies used (e.g., proton vs. photon therapy).
  2. Cause of Death Coding: Some cardiac deaths might be misclassified as "unexplained," potentially undercounting the true incidence.
  3. Retrospective Bias: While PSM helps, a retrospective study cannot account for all unmeasured confounding variables.
  4. High Censoring: Because many patients lived beyond the study period without a cardiac event, the researchers could not use certain survival models like Cox proportional hazards.

Future Work: The authors suggest that prospective studies with detailed dosimetry (measuring the exact radiation dose to specific brain regions) are needed to confirm the biological mechanisms behind this protective effect.

Summary updated

Abstract

Our study shows the influencing factors for cardiac-specific death in patients with non-malignant tumors of CNS, and found RT is associated with lower risk of cardiac-specific death. These results can facilitate the identification of patients with non-malignant tumors of CNS who can benefit from RT while avoiding cardiovascular events. In addition, this study helps to enhance the clinical use of RT in these populations, especially in patients who may have impaired cardiac function due to CNS tumors.
BibTeX
@inproceedings{wang2022effect,
  author = {Ruxin Wang and Haowen Ye and Yongting Zhao and Li Ma and Jinjing Wei and Ying Wang and Xiaofang Zhang and Lihong Wang},
  title = {{Effect of radiotherapy on cardiac-specific death in patients with non-malignant tumors of central nervous system and related clinical features}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2022},
  doi = {10.3389/fcvm.2022.991621},
}
Figure